The highest drop is over 90%! The prices of some medicines and consumables in Heilongjiang Province have dropped significantly

Medical Network News, March 12, recently, the centralized procurement of drugs and coronary dilatation balloons organized by Heilongjiang, Sichuan, Jilin, Liaoning, Inner Mongolia, Shanxi, Hainan, Gansu, Tibet and other "six provinces and two regions" alliances is on schedule.
get on.
According to the results of the bid opening, 11 drugs produced by 11 pharmaceutical companies and 68 coronary dilatation balloons produced by 26 consumables companies were eligible for selection.
Among them, the average price of 11 selected drugs decreased by 58.
05%, and the largest decrease was 91.
69%.
Drugs for common clinical diseases involving multiple systems such as respiratory, nerve, endocrine, digestion, etc.
; the average price of coronary dilatation balloons dropped from about 3248 yuan to 327 yuan, an average drop of 89.
9%, the highest drop of 93.
3%, and the lowest selected price was only 194.
5 yuan .

 

Coronary artery dilation balloon is a necessary medical consumable during coronary artery balloon dilation.
Generally speaking, the patient's fat and cholesterol accumulate in the arteries, causing arteriosclerosis, resulting in coronary artery stenosis and obstruction.
If the stenosis is small, a catheter with a balloon can be inserted to dilate the narrowed coronary artery without major cardiac surgery.
This centralized procurement will effectively reduce the medical burden of patients in the Union provinces.

 

　　In this inter-provincial alliance, a total of 11 kinds of drugs were selected in 14 product specifications, including 9 injections and 2 oral preparations, covering four types of clinically commonly used drugs such as cardiovascular and cerebrovascular diseases , liver diseases, diabetes, and digestive tract diseases.
After the selected results are executed, good medicines and cheap medicines will enter the "medicine basket" of patients.
Take the calcium acetate tablets used in patients with chronic renal failure caused by hyperphosphatemia as an example.
The price is 4.
09 yuan/tablet before the price reduction, and 0.
6242 yuan/tablet after the price reduction.
, The patient can save more than 3,500 yuan in drug costs a year by taking the drug .

 

　　In the next step, Heilongjiang Province will, in accordance with the requirements of the alliance, organize the selected companies to complete the product network and stock preparation work at the selected price, and guide medical institutions to pharmnet.
com.
cn/news/yyzb/" target="_blank">purchase the selected products as required .
It is expected that patients will use the selected products by April.
(Li Rui, CCTV reporter)

　　Medical Network News, March 12, recently, the centralized procurement of drugs and coronary dilatation balloons organized by Heilongjiang, Sichuan, Jilin, Liaoning, Inner Mongolia, Shanxi, Hainan, Gansu, Tibet and other "six provinces and two regions" alliances is on schedule.
get on.
According to the results of the bid opening, 11 drugs produced by 11 pharmaceutical companies and 68 coronary dilatation balloons produced by 26 consumables companies were eligible for selection.
Among them, the average price of 11 selected drugs decreased by 58.
05%, and the largest decrease was 91.
69%.
Drugs for common clinical diseases involving multiple systems such as respiratory, nerve, endocrine, digestion, etc.
; the average price of coronary dilatation balloons dropped from about 3248 yuan to 327 yuan, an average drop of 89.
9%, the highest drop of 93.
3%, and the lowest selected price was only 194.
5 yuan .

 

　　Coronary artery dilation balloon is a necessary medical consumable during coronary artery balloon dilation.
Generally speaking, the patient's fat and cholesterol accumulate in the arteries, causing arteriosclerosis, resulting in coronary artery stenosis and obstruction.
If the stenosis is small, a catheter with a balloon can be inserted to dilate the narrowed coronary artery without major cardiac surgery.
This centralized procurement will effectively reduce the medical burden of patients in the Union provinces.

 

　　In this inter-provincial alliance, a total of 11 kinds of drugs were selected in 14 product specifications, including 9 injections and 2 oral preparations, covering four types of clinically commonly used drugs such as cardiovascular and cerebrovascular diseases , liver diseases, diabetes, and digestive tract diseases.
After the selected results are executed, good medicines and cheap medicines will enter the "medicine basket" of patients.
Take the calcium acetate tablets used in patients with chronic renal failure caused by hyperphosphatemia as an example.
The price is 4.
09 yuan/tablet before the price reduction, and 0.
6242 yuan/tablet after the price reduction.
, The patient can save more than 3,500 yuan in drug costs a year by taking the drug .

 

　　In the next step, Heilongjiang Province will, in accordance with the requirements of the alliance, organize the selected companies to complete the product network and stock preparation work at the selected price, and guide medical institutions to pharmnet.
com.
cn/news/yyzb/" target="_blank">purchase the selected products as required .
It is expected that patients will use the selected products by April.
(Li Rui, CCTV reporter)